亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The Discovery and Development of Liraglutide and Semaglutide

赛马鲁肽 利拉鲁肽 肠促胰岛素 胰高血糖素样肽1受体 医学 2型糖尿病 药理学 糖尿病 内科学 内分泌学 受体 兴奋剂
作者
Lotte Bjerre Knudsen,Jesper F. Lau
出处
期刊:Frontiers in Endocrinology [Frontiers Media]
卷期号:10: 155-155 被引量:965
标识
DOI:10.3389/fendo.2019.00155
摘要

The discovery of glucagon-like peptide-1 (GLP-1), an incretin hormone with important effects on glycemic control and body weight regulation, led to efforts to extend its half-life and make it therapeutically effective in people with type 2 diabetes (T2D). The development of short- and then long-acting GLP-1 receptor agonists (GLP-1RAs) followed. Our article charts the discovery and development of the long-acting GLP-1 analogs liraglutide and, subsequently, semaglutide. We examine the chemistry employed in designing liraglutide and semaglutide, the human and non-human studies used to investigate their cellular targets and pharmacological effects, and ongoing investigations into new applications and formulations of these drugs. Reversible binding to albumin was used for the systemic protraction of liraglutide and semaglutide, with optimal fatty acid and linker combinations identified to maximize albumin binding while maintaining GLP-1 receptor (GLP-1R) potency. GLP-1RAs mediate their effects via this receptor, which is expressed in the pancreas, gastrointestinal tract, heart, lungs, kidneys, and brain. GLP-1Rs in the pancreas and brain have been shown to account for the respective improvements in glycemic control and body weight that are evident with liraglutide and semaglutide. Both liraglutide and semaglutide also positively affect cardiovascular (CV) outcomes in individuals with T2D, although the precise mechanism is still being explored. Significant weight loss, through an effect to reduce energy intake, led to the approval of liraglutide (3.0 mg) for the treatment of obesity, an indication currently under investigation with semaglutide. Other ongoing investigations with semaglutide include the treatment of non-alcoholic fatty liver disease (NASH) and its use in an oral formulation for the treatment of T2D. In summary, rational design has led to the development of two long-acting GLP-1 analogs, liraglutide and semaglutide, that have made a vast contribution to the management of T2D in terms of improvements in glycemic control, body weight, blood pressure, lipids, beta-cell function, and CV outcomes. Furthermore, the development of an oral formulation for semaglutide may provide individuals with additional benefits in relation to treatment adherence. In addition to T2D, liraglutide is used in the treatment of obesity, while semaglutide is currently under investigation for use in obesity and NASH.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cjy完成签到 ,获得积分10
5秒前
天天快乐的应助被飘逸小之采纳,获得10
10秒前
11秒前
Lucas的应助被诚心求文采纳,获得10
11秒前
徐志豪完成签到,获得积分10
13秒前
lwz完成签到,获得积分20
14秒前
舒适的严青完成签到,获得积分10
15秒前
泥豪泥嚎完成签到,获得积分10
15秒前
lwz发布了新的文献求助10
17秒前
weqhdgjfk完成签到,获得积分10
17秒前
19秒前
缓慢的晓夏完成签到,获得积分10
20秒前
20秒前
淡淡的向雁完成签到,获得积分0
23秒前
美满惜雪发布了新的文献求助10
24秒前
白华苍松发布了新的文献求助10
24秒前
25秒前
26秒前
cnspower的应助被科研通管家采纳,获得30
26秒前
梦梦的应助被科研通管家采纳,获得10
26秒前
心灵美平彤完成签到 ,获得积分10
30秒前
可乐完成签到,获得积分10
33秒前
shimmerringLiang完成签到 ,获得积分10
34秒前
JoyEn完成签到,获得积分10
34秒前
实验室的应助被张琼采纳,获得30
37秒前
搜集达人的应助被cfyoung采纳,获得10
41秒前
安尔完成签到 ,获得积分10
42秒前
田様的应助被儒雅的觅波采纳,获得30
43秒前
satori完成签到,获得积分10
44秒前
喜悦的乐驹完成签到,获得积分10
49秒前
欢呼的兰完成签到,获得积分10
1分钟前
ataybabdallah完成签到,获得积分10
1分钟前
深情安青的应助被辞屿采纳,获得10
1分钟前
sht完成签到,获得积分10
1分钟前
跳跃奇异果完成签到 ,获得积分10
1分钟前
西柚柚又柚完成签到,获得积分10
1分钟前
shensiang完成签到,获得积分10
1分钟前
Nicu完成签到,获得积分20
1分钟前
大模型的应助被西柚柚又柚采纳,获得10
1分钟前
chiaoyin999发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184964
求助须知:如何正确求助?哪些是违规求助? 9573917
关于积分的说明 21833687
捐赠科研通 7782425
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558672
邀请新用户注册赠送积分活动 2481161